58 Biggest Movers From Yesterday

Loading...
Loading...

Gainers

  • Pioneer Power Solutions PPSI shares climbed 205.7% to close at $4.80 on Tuesday.
  • Electro-Sensors, Inc. ELSE gained 146.4% to close at $8.50.
  • Westwater Resources, Inc. WWR shares climbed 42.5% to close at $11.80 after jumping over 87% on Monday. The company holds minerals rights for lithium and uranium deposits and strength appears related to momentum in lithium names amid EV battery interest.
  • Greenland Technologies Holding Corporation GTEC surged 32.6% to close at $2.85.
  • TransAct Technologies Incorporated TACT gained 32.4% to close at $6.75 after the company raised its Q3 sales guidance.
  • Alteryx, Inc. AYX gained 28.2% to close at $145.96 after the company raised its sales guidance for the third quarter and announced Mark Anderson as new CEO.
  • ChromaDex Corporation CDXC rose 27.5% to close at $5.19. ChromaDex highlighted publicatoin of study results showing 'nutritional protocol including nicotinamide riboside plus standard of care reduces recovery time in COVID-19 patients by nearly 30%.'
  • ReneSola Ltd SOL climbed 23.9% to close at $2.64. ReneSola, last month, priced 2.5 million ADS offering at $2 per ADS.
  • Piedmont Lithium Limited PLL shares gained 21.2% to close at $42.00. Piedmont Lithium shares jumped around 33% on Monday on continued strength after the company in late September announced it signed a sales agreement with Tesla.
  • Cogent Biosciences Inc. COGT jumped 20.9% to close at $2.84.
  • TOMI Environmental Solutions, Inc. TOMZ gained 19.8% to close at $10.24 after gaining over 15% on Monday. TOMI Environmental Solutions recently reported uplisting to the Nasdaq Capital Market.
  • Celldex Therapeutics, Inc. CLDX surged 19.5% to close at $18.16.
  • Kiniksa Pharmaceuticals, Ltd. KNSA climbed 18.3% to close at $18.74 after reporting data from Phase 2 trial of mavrilimumab in giant cell arteritis. The trial achieved both the primary and secondary efficacy endpoints with statistical significance.
  • Humanigen, Inc. HGEN jumped 17% to close at $14.20. Humanigen, on Friday, issued updates on Lenzilumab in COVID-19 program.
  • IKONICS Corporation IKNX rose 16.8% to close at $3.90.
  • Group 1 Automotive, Inc. GPI rose 16.3% to close at $118.62 after the company issued Q3 preliminary EPS above analyst estimates and announced a $200 million buyback. The company also said it intends to reinstate its dividend.
  • Personalis, Inc. PSNL gained 16.2% to close at $28.20.
  • Emerald Holding, Inc. EEX shares climbed 15.1% to close at $2.67 after the company announced it authorized a $20 million buyback program.
  • Beam Therapeutics Inc. BEAM rose 14.8% to close at $27.39. Beam Therapeutics recently announced a proposed public offering of common stock of 4.5 million shares.
  • Broadwind, Inc. BWEN surged 14.3% to close at $3.52.
  • Endo International plc ENDP rose 14.1% to close at $4.25. Endo International, last month, announced a non-exclusive agreement with Novavax to provide fill-finish manufacturing services at its Rochester, Michigan plant for its NVX-CoV2373 COVID-19 vaccine candidate.
  • Neuronetics, Inc. STIM gained 13% to close at $5.84. BTIG reiterated Neuronetics with a Buy and raised the price target from $6 to $10.
  • Comstock Holding Companies, Inc. CHCI rose 12.6% to close at $2.87.
  • China Recycling Energy Corporation CREG rose 12.3% to close at $3.92.
  • XpresSpa Group, Inc. XSPA shares gained 12% to close at $2.53 after gaining around 18% on Monday.
  • Gamida Cell Ltd. GMDA climbed 9.5% to close at $4.60 after the company announced its Phase 3 clinical study of Omidubicel met all three of its secondary endpoints.
  • DBV Technologies S.A. DBVT gained 7.9% to close at $1.78.
  • Himax Technologies, Inc. HIMX rose 7.8% to close at $3.73 following strong preliminary results for the third quarter.
  • Polar Power, Inc. POLA gained 6.3% to close at $4.05.
  • BioNTech SE BNTX rose 6.1% to close at $85.59. BioNTech and Pfizer reported the initiation of rolling submission to the EMA for SARS-CoV-2 vaccine candidate BNT162b2.
  • Jaguar Health, Inc. JAGX gained 5.8% to close at $0.3280 after the company announced it has met the financial condition for the sale of royalty rights for Mytesi.
  • Naked Brand Group Limited NAKD shares rose 5.7% to close at $0.12 as the company’s subsidiary, Bendon, entered into a settlement deal with Timothy Connell, William Gibson and Ivory Castle.
  • Tata Motors Limited TTM rose 5.4% to close at $9.70.
  • Can Fite Biopharma ADR CANF gained 5.1% to close at $1.84 after an independent data monitoring committee recommended the company to continue with Phase III psoriasis study.
  • Invitae Corporation NVTA gained 4.7% to close at $47.51 after it was announced Taysha Gene Therapy and the company partnered to enabled rapid access to genetic testing and earlier diagnosis of patients with CNS disease and large-market indications.

 

Check out these big penny stock gainers and losers

Losers

  • Corbus Pharmaceuticals Holdings, Inc. CRBP shares tumbled 36% to close at $1.21 on Tuesday after the company announced its Phase 2b study of Lenabasum for treatment of cystic fibrosis did not meet the primary endpoint.
  • Axovant Gene Therapies Ltd. AXGT fell 26.3% to close at $4.15. Axovant reported positive six-month follow-up data from second cohort of SUNRISE-PD Phase 2 trial of AXO-Lenti-PD gene therapy.
  • Miragen Therapeutics, Inc. MGEN declined 23.5% to close at $0.5815 after the company announced that it conducted an internal review of preliminary topline data from its Phase 2 SOLAR clinical trial of cobomarsen in patients with Cutaneous T-Cell Lymphoma. The press release said preliminary data in 37 patients suggest that cobomarsen lacks a compelling result for the study's primary endpoint.
  • Palomar Holdings, Inc. PLMR shares declined 19.1% to close at $88.02. Palomar Holdings said it expects pretax catastrophe losses of $34 million to $38 million, net of reinsurance, during the third quarter.
  • Gold Resource Corporation GORO fell 16% to close at $2.79. Gold Resource recently announced plans to spin-off its Nevada Mining Unit to shareholders as a separate, publicly-traded company.
  • Synalloy Corporation SYNL fell 15.1% to close at $3.98.
  • Hyliion Holdings Corp. HYLN declined 15% to close at $33.28. On Friday, Hyliion shares dropped 12% in first day of post-SPAC merger trading.
  • VivoPower International PLC VVPR fell 14.7% to close at $9.80. Vivopower International, last month, announced a non-binding letter of intent to buy a 51% of Tembo 4x4 for $4.7 million.
  • Corvus Pharmaceuticals, Inc. CRVS dropped 14.2% to close at $4.17. Corvus Pharmaceuticals recently announced positive early results from a study of its potential COVID-19 treatment.
  • ProPhase Labs, Inc. PRPH dipped 13.9% to close at $5.93. ProPhase Labs recently announced plans to explore the acquisition of one or more CLIA accredited labs suitable for COVID-19 and other testing.
  • Social Capital Hedosophia Holdings Corp. III IPOC declined 13.5% to close at $10.97. Alphabet and Sequoia-backed insurance startup Clover Health plans to go public via a merger with blank check company Social Capital Hedosophia Holdings Corp. III, reports the New York Times.
  • Lithium Americas Corp. LAC shares fell 13.1% to close at $13.79.
  • Nam Tai Property Inc. NTP declined 12.9% to close at $6.01. Nam Tai Property shares tumbled 26% on Monday as the company raised $170 million through private placement transaction.
  • Iovance Biotherapeutics, Inc. IOVA dropped 12.4% to close at $28.10. Following a recent Type B meeting with the FDA, Iovance Biotherapeutics said it has not been able to agree with the FDA on the required potency assays to fully define its tumor-infiltrating lymphocyte therapy lifileucel in metastatic melanoma, which is required as part of a BLA submission. Wells Fargo downgraded Iovance Biotherapeutics from Overweight to Equal-Weight and lowered the price target from $49 to $29.
  • Pacific Drilling S.A. PACD dipped 12.2% to close at $0.2580 after rising 5% on Monday.
  • Beam Global BEEM fell 11.9% to close at $15.37.
  • ThermoGenesis Holdings, Inc. THMO fell 10.6% to close at $2.61.
  • Inpixon INPX dropped 9.8% to close at $1.11. Inpixon yesterday announced plans to buy Nanotron for $8.7 million.
  • Y-mAbs Therapeutics, Inc YMAB shares fell 8.6% to close at $38.13 after the company reported it received a Refusal to File letter from the FDA regarding the Biologics License Application for omburtamab for the treatment of patients with neuroblastoma.
  • Artelo Biosciences, Inc. ARTL fell 7.3% to close at $1.01 after surging over 26% on Monday. Artelo Biosciences, last week, received Ethics Committee approval in the UK to commence its Phase I/II study of ART27.13.
  • Lightbridge Corporation LTBR slipped 6.2% to close at $3.81.
  • Logitech International S.A. LOGI fell 6.1% to close at $75.83 after Apple removed third-party audio products from its stores.. Logitech is expected to release quarterly earnings on October 19.
  • PIMCO Dynamic Income Fund PDI fell 4.5% to close at $24.68 after the company announced a public offering of 3 million shares of common stock.
Loading...
Loading...
Posted In: NewsPenny StocksPre-Market OutlookMarketsMoversTrading IdeasComputer Storage & PeripheralsInformation TechnologyMovers From YesterdayTop Gainers
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...